Manufacturer record
Snehal Pharma & Surgicals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Snehal Pharma & Surgicals Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between July 2022 and July 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T24B008, Diclofenac Tablets IP 50mg (Snedic- 50) (exp Jan 2027). CDTL Mumbai (CDSCO lab) found it not of standard quality: Misbranded (Improper labeling). Listed in the July 2024 alert.
Records by type
2 records linked to Snehal Pharma & Surgicals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Tablets IP 50mg (Snedic- 50) | Batch T24B008Mfg Feb 2024 · Exp Jan 2027 | Misbranded (Improper labeling)Misbranded | CDTL MumbaiCDSCO lab | Jul 2024 |
| Snelgy-M (Montelukast 10 mg & Levocetirizine 5 mg Tablets) | Batch T21G003Mfg Jul 2021 · Exp Jun 2023 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jul 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.